search
Back to results

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

Primary Purpose

Hydrops in Keratoconus

Status
Completed
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Gas SF6 (Sulfur Hexafluoride)
Sponsored by
HaEmek Medical Center, Israel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hydrops in Keratoconus

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Hydrops

Exclusion Criteria:

  • Age < 18 years old

Sites / Locations

  • HaEmek Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

Outcomes

Primary Outcome Measures

Hydrops resulotion

Secondary Outcome Measures

Full Information

First Posted
January 1, 2008
Last Updated
February 12, 2020
Sponsor
HaEmek Medical Center, Israel
search

1. Study Identification

Unique Protocol Identification Number
NCT00593190
Brief Title
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
January 2008 (Actual)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
May 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
HaEmek Medical Center, Israel

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hydrops in Keratoconus

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Gas SF6 (Sulfur Hexafluoride)
Intervention Description
ONCE
Primary Outcome Measure Information:
Title
Hydrops resulotion
Time Frame
weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Hydrops Exclusion Criteria: Age < 18 years old
Facility Information:
Facility Name
HaEmek Medical Center
City
Afula
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus

We'll reach out to this number within 24 hrs